Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-259613
Filing Date
2022-10-07
Accepted
2022-10-07 16:16:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d376462ds3.htm S-3 178223
2 EX-5.1 d376462dex51.htm EX-5.1 5698
3 EX-23.1 d376462dex231.htm EX-23.1 2111
4 EX-23.2 d376462dex232.htm EX-23.2 2016
5 EX-FILING FEES d376462dexfilingfees.htm EX-FILING FEES 31501
6 GRAPHIC g376462g04j69.jpg GRAPHIC 56635
7 GRAPHIC g376462g1006163756573.jpg GRAPHIC 2253
8 GRAPHIC g376462g1006163756776.jpg GRAPHIC 3710
9 GRAPHIC g376462g1006163756901.jpg GRAPHIC 5122
  Complete submission text file 0001193125-22-259613.txt   314653
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267781 | Film No.: 221300936
SIC: 2834 Pharmaceutical Preparations